Sinclair Pharma PLC Director/PDMR Shareholding (0601C)
January 17 2018 - 2:00AM
UK Regulatory
TIDMSPH
RNS Number : 0601C
Sinclair Pharma PLC
17 January 2018
Sinclair Pharma plc
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L)
("Sinclair" or the "Group"), the international aesthetics company,
was advised on 16 January 2018, that on that day, Jeff Thompson,
Non-Executive Director, acquired 200,000 ordinary shares of 1p each
("Ordinary Shares") in the Group at an average price of 23.1p per
Ordinary Share.
Following these purchases, Jeff Thompson's total beneficial
interest is 350,000 Ordinary Shares, 0.07% of the issued share
capital of the Group.
For further information please contact:
Sinclair Pharma Tel: +44 (0)
plc 20 7467 6920
Chris Spooner
Alan Olby
Andy Crane
Peel Hunt LLP (NOMAD and Tel: +44 (0) 20 7418
Joint Broker) 8900
James Steel
Oliver Jackson
RBC Capital Markets (Joint Tel: +44 (0) 20 7653
Broker) 4000
Marcus Jackson
Laura White
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------------
a. Name Jeff Thompson
--- ------------------------------ --------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a. Position/status Non-Executive Director
--- ------------------------------ --------------------------------
b. Initial Initial Announcement
notification
/Amendment
--- ------------------------------ --------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a. Name Sinclair Pharma plc
--- ------------------------------ --------------------------------
b. LEI 213800BNMD7JVMHW1772
--- ------------------------------ --------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a. Description Ordinary Shares of 1 pence each
of the in Sinclair Pharma plc
Financial
instrument,
type
of instrument GB0033856740
Identification
code
--- ------------------------------ --------------------------------
b. Nature of Purchase
the transaction
--- ------------------------------ --------------------------------
c. Price(s) Price(s) Volume(s)
and volume(s) --------- ----------
23.1p 200,000
--------- ----------
--- ------------------------------ --------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------------ --------------------------------
e. Date of 2018-01-16
the transaction
--- ------------------------------ --------------------------------
f. Place of London Stock Exchange, AIM
the transaction
--- ------------------------------ --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDQLFFVFFLBBD
(END) Dow Jones Newswires
January 17, 2018 02:00 ET (07:00 GMT)
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2023 to Apr 2024